Filter
27
Text search:
Hussein
Ahmed
Featured
Recommendations
3
New Publications
6
Language
Document type
No document type
11
Studies & Reports
8
Guidelines
3
Fact sheets
2
Manuals
1
Training Material
1
Strategic & Response Plan
1
Countries / Regions
Global
5
Somalia
4
Ethiopia
3
Yemen
2
Liberia
1
Congo, Democratic Republic of
1
South Sudan
1
Germany
1
Syria
1
Kenya
1
Tanzania
1
Bangladesh
1
Central African Republic
1
Colombia
1
Ecuador
1
Mexico
1
Myanmar / Burma
1
Middle East and North Africa
1
Africa
1
Venezuela
1
Iran
1
Authors & Publishers
Publication Years
Category
Countries
11
Clinical Guidelines
4
Women & Child Health
3
Public Health
2
Key Resources
2
Capacity Building
1
Annual Report MEDBOX
1
Toolboxes
Conflict
2
NCDs
2
Cholera
1
Natural Hazards
1
Refugee
1
Mental Health
1
TB
1
AMR
1
COVID-19
1
Caregiver
1
NTDs
1
Health Financing Toolbox
1
Evidence shows that FGM can cause several physical, mental and sexual health complications in girls and women, and in newborns. Health-care providers play an important role in supporting girls and women living with FGM, and improving their health and well-being. They are in a unique position to infl
...
Background document to the 2018 joint statement by WHO, UNFPA, UNICEF, ICM, ICN, FIGO and IPA: definition of skilled health personnel providing care during childbirth
Globally, it is estimated that 128.6 million people are currently in need of humanitarian assistance. Of these individuals, approximately one-fourth are women and girls of reproductive age. Although family planning is one of the most life-saving, empowering, and cost-effective interventions for wome
...
Internationally, there is a growing concern over antimicro-bial resistance (AMR) which is currently estimated to ac-count for more than 700,000 deaths per year worldwide. If no appropriate measures are taken to halt its pro-gress, AMR will cost approximately 10 million lives andabout US$100 trillion
...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma
...
